Williams, R. ., de Vries, F. ., Kothny, W. ., Serban, C. ., Lopez-Leon, S. ., Chu, C. ., & Schlienger, R. . (2017). Cardiovascular safety of vildagliptin in patients with type 2 diabetes: A European multi-database, non-interventional post-authorization safety study. Diabetes Obes Metab. http://doi.org/10.1111/dom.12951
W. Kothny
First name
W.
Last name
Kothny
Williams, R. ., Kothny, W. ., Serban, C. ., Lopez-Leon, S. ., & Schlienger, R. . (2019). Pancreatic safety of vildagliptin in patients with type 2 diabetes mellitus: A European, noninterventional, postauthorization safety study. Endocrinol Diabetes Metab. http://doi.org/10.1002/edm2.52
Williams, R. ., Kothny, W. ., Serban, C. ., Lopez-Leon, S. ., de Vries, F. ., & Schlienger, R. . (2019). Association between vildagliptin and risk of angioedema, foot ulcers, skin lesions, hepatic toxicity, and serious infections in patients with type 2 diabetes mellitus: A European multidatabase, noninterventional, postauthorization safety study. Endocrinol Diabetes Metab. http://doi.org/10.1002/edm2.84